|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-14 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
Stock exchange
Nasdaq- $
-
0
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| CASI | 0.1530USD | 0.00% | 102.05 $ |
Basic data
Market Cap (USD)
3,145,048
Net sales (USD)
20,712,000
Free-Float
53.62 %
Free-Float capitalization (USD)
1,720,183
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 3.15M | |
| -1.61% | -2.89% | +53.53% | +104.34% | 1,034B | |
| -1.01% | +2.85% | +54.21% | +71.56% | 671B | |
| -1.45% | +0.41% | +20.43% | +75.58% | 460B | |
| +0.14% | -0.47% | +29.49% | +38.56% | 353B | |
| -1.33% | +4.72% | +24.69% | +45.55% | 309B | |
| -1.15% | +0.30% | -1.49% | +12.31% | 255B | |
| -1.59% | +1.02% | +55.96% | +71.98% | 240B | |
| -0.88% | +1.15% | -17.09% | -54.39% | 207B | |
| -0.56% | +3.42% | +33.60% | +100.46% | 188B | |
| Average | -1.01% | +1.27% | +28.15% | +51.77% | 371.68B | |
| Weighted average by Cap. | -1.14% | +1.04% | +36.31% | +66.27% |
Historical Quotes: ENTREMED
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- CASIF Stock
- Stock
- Quotes ENTREMED
Select your edition
All financial news and data tailored to specific country editions
